BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38191511)

  • 1. Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients.
    Vervuurt M; Schrader JM; de Kort AM; Kersten I; Wessels HJCT; Klijn CJM; Schreuder FHBM; Kuiperij HB; Gloerich J; Van Nostrand WE; Verbeek MM
    Acta Neuropathol Commun; 2024 Jan; 12(1):6. PubMed ID: 38191511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of urokinase plasminogen activator in rodent models and patients with cerebral amyloid angiopathy.
    Vervuurt M; Zhu X; Schrader J; de Kort AM; Marques TM; Kersten I; Peters van Ton AM; Abdo WF; Schreuder FHBM; Rasing I; Terwindt GM; Wermer MJH; Greenberg SM; Klijn CJM; Kuiperij HB; Van Nostrand WE; Verbeek MM
    Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12804. PubMed ID: 35266166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust neuroinflammation and perivascular pathology in rTg-DI rats, a novel model of microvascular cerebral amyloid angiopathy.
    Zhu X; Hatfield J; Sullivan JK; Xu F; Van Nostrand WE
    J Neuroinflammation; 2020 Mar; 17(1):78. PubMed ID: 32127016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Levels of Cerebrospinal Fluid/Plasma Aβ40 as an Early Biomarker for Cerebral Amyloid Angiopathy in RTg-DI Rats.
    Zhu X; Xu F; Hoos MD; Lee H; Benveniste H; Nostrand WEV
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Cognitive Decline in a Novel Rodent Model of Cerebral Amyloid Angiopathy Type-1.
    Popescu DL; Van Nostrand WE; Robinson JK
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal markers of cerebral amyloid angiopathy and related inflammation in rTg-DI rats.
    Schrader JM; Xu F; Agostinucci KJ; DaSilva NA; Van Nostrand WE
    Sci Rep; 2024 Apr; 14(1):8441. PubMed ID: 38600214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy.
    De Kort AM; Kuiperij HB; Marques TM; Jäkel L; van den Berg E; Kersten I; van Berckel-Smit HEP; Duering M; Stoops E; Abdo WF; Rasing I; Voigt S; Koemans EA; Kaushik K; Warren AD; Greenberg SM; Brinkmalm G; Terwindt GM; Wermer MJH; Schreuder FHBM; Klijn CJM; Verbeek MM
    Ann Neurol; 2023 Jun; 93(6):1173-1186. PubMed ID: 36707720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Brain Proteomic Signatures in Cerebral Small Vessel Disease Rat Models of Hypertension and Cerebral Amyloid Angiopathy.
    Schrader JM; Stanisavljevic A; Xu F; Van Nostrand WE
    J Neuropathol Exp Neurol; 2022 Aug; 81(9):731-745. PubMed ID: 35856898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct brain regional proteome changes in the rTg-DI rat model of cerebral amyloid angiopathy.
    Schrader JM; Xu F; Van Nostrand WE
    J Neurochem; 2021 Oct; 159(2):273-291. PubMed ID: 34218440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proximity extension assay in cerebrospinal fluid identifies neurofilament light chain as biomarker of neurodegeneration in sporadic cerebral amyloid angiopathy.
    Vervuurt M; Kuiperij HB; de Kort AM; Kersten I; Klijn CJM; Schreuder FHBM; Verbeek MM
    Alzheimers Res Ther; 2024 May; 16(1):108. PubMed ID: 38745197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Non-pharmacological Chronic Hypertension on a Transgenic Rat Model of Cerebral Amyloid Angiopathy.
    Stanisavljevic A; Schrader JM; Zhu X; Mattar JM; Hanks A; Xu F; Majchrzak M; Robinson JK; Van Nostrand WE
    Front Neurosci; 2022; 16():811371. PubMed ID: 35368255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rTg-D: A novel transgenic rat model of cerebral amyloid angiopathy Type-2.
    Davis J; Xu F; Zhu X; Van Nostrand WE
    Cereb Circ Cogn Behav; 2022; 3():100133. PubMed ID: 36324401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Transgenic Rat Model of Robust Cerebral Microvascular Amyloid with Prominent Vasculopathy.
    Davis J; Xu F; Hatfield J; Lee H; Hoos MD; Popescu D; Crooks E; Kim R; Smith SO; Robinson JK; Benveniste H; Van Nostrand WE
    Am J Pathol; 2018 Dec; 188(12):2877-2889. PubMed ID: 30446159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy.
    Vervuurt M; de Kort AM; Jäkel L; Kersten I; Abdo WF; Schreuder FHBM; Rasing I; Terwindt GM; Wermer MJH; Greenberg SM; Klijn CJM; Kuiperij HB; Verbeek MM
    Alzheimers Res Ther; 2023 Jan; 15(1):26. PubMed ID: 36717932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy.
    de Kort AM; Kuiperij HB; Jäkel L; Kersten I; Rasing I; van Etten ES; van Rooden S; van Osch MJP; Wermer MJH; Terwindt GM; Schreuder FHBM; Klijn CJM; Verbeek MM
    Alzheimers Res Ther; 2023 Jun; 15(1):102. PubMed ID: 37270536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse white matter loss in a transgenic rat model of cerebral amyloid angiopathy.
    Lee H; Xu F; Liu X; Koundal S; Zhu X; Davis J; Yanez D; Schrader J; Stanisavljevic A; Rothman DL; Wardlaw J; Van Nostrand WE; Benveniste H
    J Cereb Blood Flow Metab; 2021 May; 41(5):1103-1118. PubMed ID: 32791876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Copper Chelation Therapy in a Transgenic Rat Model of Cerebral Amyloid Angiopathy.
    Ambi A; Stanisavljevic A; Victor TW; Lowery AW; Davis J; Van Nostrand WE; Miller LM
    ACS Chem Neurosci; 2023 Feb; 14(3):378-388. PubMed ID: 36651175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
    Banerjee G; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Dickson JC; Fraioli F; Groves AM; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
    J Alzheimers Dis; 2020; 74(4):1189-1201. PubMed ID: 32176643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    van den Berg E; Nilsson J; Kersten I; Brinkmalm G; de Kort AM; Klijn CJM; Schreuder FHBM; Jäkel L; Gobom J; Portelius E; Zetterberg H; Brinkmalm A; Blennow K; Kuiperij HB; Verbeek MM
    J Alzheimers Dis; 2023; 92(2):467-475. PubMed ID: 36776062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.